Janos L. Tanyi, MD, PhD, of Penn Medicine, shared an early report of a new type of CAR T cell therapy, called KIR-CAR, in a Clinical Trial Plenary session at the AACR Annual Meeting 2026.

Researchers have found a way to make cancer-killing immune cells more powerful and precise. By adding specific signaling components, they boosted the cells’ readiness to attack tumors. Surprisingly, ...

Chimeric antigen receptor, or CAR, therapy is no longer just a cancer story. This review shows how the field is expanding beyond conventional CAR-T cells into a wider family of engineered cell ...

Botanical ingredients like curcumin, ashwagandha and quercetin continue to gain traction in immune health, but questions ...

Chemokines, acting as "traffic controllers" in the tumor microenvironment, regulate immune cell infiltration and local ...

Verismo Therapeutics, a clinical-stage CAR T cell therapy company pioneering a novel multichain KIR-CAR platform technology, ...

What is Glutathione? It is known as the 'Master Antioxidant.' Discover what Glutathione is, how it detoxifies the liver, ...

The specific mix of bacteria living in a person's gut can predict the chances that melanoma will recur after surgery and ...

The Ordinary’s exfoliating toner is a staple for glowing skin — and reviewers say it doubles as an underarm odor fix.

SAN DIEGO - An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of ...

Gut microbial profiles reveal recurrence risk in melanoma patients, with region-specific patterns enabling accurate ...